283 related articles for article (PubMed ID: 32850345)
21. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma.
Ning P; Gao F; Hai J; Wu M; Chen J; Zhu S; Wang M; Shi D
Abdom Radiol (NY); 2020 Jan; 45(1):64-72. PubMed ID: 31486869
[TBL] [Abstract][Full Text] [Related]
22. A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer.
Chu Y; Li J; Zeng Z; Huang B; Zhao J; Liu Q; Wu H; Fu J; Zhang Y; Zhang Y; Cai J; Zeng F
Front Oncol; 2020; 10():575422. PubMed ID: 33178604
[No Abstract] [Full Text] [Related]
23. A radiomics signature associated with underlying gene expression pattern for the prediction of prognosis and treatment response in hepatocellular carcinoma.
Wang D; Zhang L; Sun Z; Jiang H; Zhang J
Eur J Radiol; 2023 Oct; 167():111086. PubMed ID: 37708675
[TBL] [Abstract][Full Text] [Related]
24. Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.
Bai H; Meng S; Xiong C; Liu Z; Shi W; Ren Q; Xia W; Zhao X; Jian J; Song Y; Ni C; Gao X; Li Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1524-1533. PubMed ID: 35896687
[TBL] [Abstract][Full Text] [Related]
25. Integration of Multimodal Computed Tomography Radiomic Features of Primary Tumors and the Spleen to Predict Early Recurrence in Patients with Postoperative Adjuvant Transarterial Chemoembolization.
Chen C; Liu J; Gu Z; Sun Y; Lu W; Liu X; Chen K; Ma T; Zhao S; Zhao H
J Hepatocell Carcinoma; 2023; 10():1295-1308. PubMed ID: 37576612
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Interpretability Analysis of Noninvasive Imaging Based on Computed Tomography in Patients with Hepatocellular Carcinoma After Initial Transarterial Chemoembolization.
Dai Y; Liu D; Xin Y; Li Y; Wang D; He B; Zeng X; Li J; Jia F; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S61-S72. PubMed ID: 37393179
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model.
Jiang Y; Sun J; Xia Y; Cheng Y; Xie L; Guo X; Guo Y
Front Oncol; 2021; 11():644994. PubMed ID: 33937051
[No Abstract] [Full Text] [Related]
28. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
[TBL] [Abstract][Full Text] [Related]
29. A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker.
Ivanics T; Salinas-Miranda E; Abreu P; Khalvati F; Namdar K; Dong X; Deniffel D; Gorgen A; Erdman L; Jhaveri K; Haider M; Veit-Haibach P; Sapisochin G
Transplantation; 2021 Nov; 105(11):2435-2444. PubMed ID: 33982917
[TBL] [Abstract][Full Text] [Related]
30. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
[TBL] [Abstract][Full Text] [Related]
31. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
Luo J; Huang Z; Wang M; Li T; Huang J
BMC Gastroenterol; 2022 Mar; 22(1):108. PubMed ID: 35260095
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization: A Real-World Study Based on Non-Contrast Computed Tomography Radiomics and General Image Features.
Guo Z; Zhong N; Xu X; Zhang Y; Luo X; Zhu H; Zhang X; Wu D; Qiu Y; Tu F
J Hepatocell Carcinoma; 2021; 8():773-782. PubMed ID: 34277508
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
35. Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma.
Zou J; Yuan J; Chen H; Zhou X; Xue T; Chen R; Zhang L; Ren Z
J Gastrointest Oncol; 2022 Jun; 13(3):1376-1383. PubMed ID: 35837157
[TBL] [Abstract][Full Text] [Related]
36. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model.
Zhang X; He Z; Zhang Y; Kong J
Front Pharmacol; 2024; 15():1315732. PubMed ID: 38344175
[No Abstract] [Full Text] [Related]
37. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.
Xue B; Wu S; Zhang M; Hong J; Liu B; Xu N; Zeng Q; Tang K; Zheng X
Abdom Radiol (NY); 2021 Aug; 46(8):3835-3844. PubMed ID: 33728532
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features.
Tipaldi MA; Ronconi E; Lucertini E; Krokidis M; Zerunian M; Polidori T; Begini P; Marignani M; Mazzuca F; Caruso D; Rossi M; Laghi A
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34073545
[TBL] [Abstract][Full Text] [Related]
39. CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy.
Liu Y; Wei X; Zhang X; Pang C; Xia M; Du Y
Transl Oncol; 2022 Dec; 26():101536. PubMed ID: 36115077
[TBL] [Abstract][Full Text] [Related]
40. Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.
Chen M; Cao J; Hu J; Topatana W; Li S; Juengpanich S; Lin J; Tong C; Shen J; Zhang B; Wu J; Pocha C; Kudo M; Amedei A; Trevisani F; Sung PS; Zaydfudim VM; Kanda T; Cai X
Liver Cancer; 2021 Feb; 10(1):38-51. PubMed ID: 33708638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
